About iBIONICS
Cochlear is a $10-billion company that has sold half a million implants so deaf people can hear. Cochlear’s innovative and commercial success inspired the Australian Government to create a Bionic Vision Fund. $12-million was allocated to the diamond retina implant development. iBIONICS incorporated in Canada in November 2015 to further develop and commercialize the Diamond Eye™. The company benefits from deep ecosystems of expertise:
Australian Sensory Bionics
Canadian Digital Wireless Technology
Seeing and Being Seen
A healthy retina converts incoming light to electric pulses, which is the brain’s language—our brains are digital! In a degenerating retina, that connection is broken, and sight is lost. The solution is iBIONICS’ Diamond Eye, a bionic retina.
The Problem
Over 200 million people, born with sight, are afflicted with Age-Related Macular Degeneration (AMD) or Retinitis Pigmentosa (RP) leading to blindness.
The Costs
Blindness is debilitating, stealing autonomy from individuals and comes with a high societal cost.
The Solution
The Australia-developed Diamond Eye™ technology, supported by a made-in-Canada wireless solution for implantable bionic devices, will return partial vision to the blind.
The iBIONICS Team
iBIONICS leaders possess a wealth of experience in implantable sensory bionics, bringing smart visual solutions to global markets, wireless technologies, neurotechnology and clinical expertise. They retain laser-sharp focus and innovative global perspective while living a collaborative culture of compassionate strength and ambitious brilliance.